Literature DB >> 18973610

Winning combination: the additive/synergistic benefits of IVIg in corticosteroid refractory optic neuritis.

A Achiron.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973610     DOI: 10.1111/j.1468-1331.2008.02257.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  5 in total

1.  Outcomes of toll-like receptors' antagonism in steroid-resistant optic neuritis; a pilot study.

Authors:  Aditya Sudhalkar; Mayuri Khamar; Bakulesh Khamar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-15       Impact factor: 3.117

2.  Mycobacterium W administration for steroid resistant optic neuritis with long-term follow-up.

Authors:  Aditya Sudhalkar; Mayuri Khamar; Bakulesh Khamar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-18       Impact factor: 3.117

3.  Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.

Authors:  Elizabeth M Cameron; Sade Spencer; Jonathan Lazarini; Christopher T Harp; E Sally Ward; Mark Burgoon; Gregory P Owens; Michael K Racke; Jeffrey L Bennett; Elliot M Frohman; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2009-07-24       Impact factor: 3.478

4.  Co-existence of multiple sclerosis and germinoma in an adult male: Case report.

Authors:  Jan Bian; Alison Westrup; Sarah Sung; Nidhiben A Anadani; Kar-Ming Fung; Andrew K Conner
Journal:  Surg Neurol Int       Date:  2021-04-19

Review 5.  Re-evaluating the treatment of acute optic neuritis.

Authors:  Jeffrey L Bennett; Molly Nickerson; Fiona Costello; Robert C Sergott; Jonathan C Calkwood; Steven L Galetta; Laura J Balcer; Clyde E Markowitz; Timothy Vartanian; Mark Morrow; Mark L Moster; Andrew W Taylor; Thaddeus W W Pace; Teresa Frohman; Elliot M Frohman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-10-29       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.